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An attenuated live vaccine is a candidate in developing vaccines against human immunodeficiency virus type 1 (HIV-1). The
study using macaques and simian immunodeficiency virus (SIVmac) showed an attenuated virus to be more effective than
any other vaccine candidate. However, development of a safer vaccine is required for clinical application. In this study, we
constructed pSIVmac D nef with tetracycline inducible promoter (pTet) and tried to control viral expression in a drug-
dependent manner. Promoter/enhancer motifs in the U3 region of the long terminal repeats (LTRs) were serially deleted and
replaced with pTet. In mutant LTRs, which lack NF-kB and Sp1 binding sites, TATA box motifs, and the 59 half of the U3 region,
promoter activity was stringently controlled by doxycycline (Dox). Their activities were similar to or higher than that of
wild-type LTR in the presence of Dox, based on the transient chloramphenicol acetyltransferase reporter assay. Three of
these mutant LTRs were introduced into the pSIVmac239 D nef genome. Viral protein from these viruses was efficiently
expressed in a Dox-dependent manner after transfection to a HeLa cell, which expresses reverse tetracycline transactivator
(rtTA). The 2-LTR-form viral DNA of these viruses could be detected in M8166 cells that had been infected with supernatants
from the transfected rtTA HeLa cell. These results suggest that pSIVmac D nef containing mutant LTRs can proceed through
one viral replication cycle consisting of transcription, formation of viral particles, infection to cells, and reverse transcription.
Although continuous replication of these Dox-dependent viruses requires a supply of rtTA as a constituent for the pTet-On
viral genome, the successful replacement of the original promoter with a drug-dependent promoter suggests a new
possibility for developing a safer attenuated live virus. © 2000 Academic Press
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The macaque model has become an essential tool in
the development of vaccine against acquired immuno-
deficiency syndrome (AIDS). The close similarities be-
tween the virus and disease in macaques and humans
suggest that a vaccine strategy that works in monkeys
may have a similar efficacy in human. Daniel et al. (1992)
and others (Almond et al., 1995; Gundlach et al., 1998)
have shown that live attenuated simian immunodefi-
ciency viruses (SIVs) with nef deletion mutation are the
most effective vaccines tested so far in the SIV macaque
model. However, these attenuated SIVs cause disease
when administered orally to newborn macaques (Baba et
al., 1995). For human use, the replication and pathoge-
nicity of attenuated vaccines need to be controlled more
stringently.
The major transcriptional regulatory elements reside
within the long terminal repeat (LTR) U3 region in all
retroviruses (Varmus, 1988). In the case of SIVmac239,
this region includes the TATA box motif and binding sites
for transcriptional factors NK-kB and Sp1. These motifs
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268re located 80 to 100 bp upstream of the 39 terminus of
he U3 region. The 59 half of the U3 region, which does
ot contain any transcriptional motifs, overlaps the nef
oding frame (407 bp) (Regier and Desrosiers, 1990). The
pstream region of the U3 sequence in SIVmac239 can
e selectively deleted in vivo in the absence of an intact
ef gene (Kirchhoff et al., 1994). Also, SIVmac lacking
inding sites for NF-kB and Sp1 can replicate as well as
that of wild-type SIVmac239 and induce AIDS-like symp-
toms in the rhesus monkey (Macaca mulatta) (Ilyinskii
and Desrosiers, 1996; Ilyinskii et al., 1997). These reports
uggest that these sequences are not required for virus
ropagation. Moreover, the binding sites for NF-kB and
Sp1 in HIV-1 can be replaced by cytomegalovirus (CMV)
promoter without abolishing the virus’ ability to replicate
(Chang et al., 1993). The successful replacement of a
promoter in HIV-1 raises hopes of constructing an atten-
uated SIVmac239 with a heterogeneous regulatory pro-
moter.
The tetracycline (tet) inducible transcription activation
system described by Gossen and Bujard (1992) has been
shown to function as an efficient genetic switch in mam-
malian cells (Gossen et al., 1995) and transgenic mice
(Furth et al., 1994). It consists of constitutive expression
of the tet transactivator protein (tTA) and tet inducible
promoter (pTet). tTA is a fusion protein composed of the
tet repressor of Escherichia coli and the transcriptional
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269Dox-DEPENDENT SIVmac WITH TETRACYCLINE-INDUCIBLE PROMOTERactivation domain of the VP16 protein of herpes simplex
virus. pTet contains the CMV immediate-early (IE) mini-
mal promoter preceded by seven copies of the tet-resis-
tant operator. The gene to be regulated by transactivator
tTA is placed under the control of this hybrid inducible
promoter. The tet repressor portion of tTA can mediate
high-affinity binding only in the absence of tet and spe-
cific binding to the sequences of tet resistance operator
[tet(O)7], leading to the subsequent activation of tran-
scription. On the other hand, the transactivator rtTA with
reverse phenotype requires tet derivatives, like doxycy-
cline (Dox), for binding to its operator and thus activates
transcription only in the presence of the tet effector
(Gossen et al., 1995). This Tet-on system now has many
applications in various fields of medical research (Bi-
eschke et al., 1998) using mice (Mansuy et al., 1998),
transgenic mice (Kistner et al., 1996), and a versatile
vector for gene therapy (Lindemann et al., 1997).
To make a safer attenuated SIVmac239 vaccine, we
used Dox to regulate virus expression in mutant SIV, by
replacing the original LTR U3 promoter in an apatho-
genic pSIVmac239 D nef clone with a tet inducible pro-
FIG. 1. Schematic representation of the location of the transcription
The length of the U3 transcriptional element deletion in MLTRCAT rep
mutant LTRs are given in detail under Materials and Methods.moter, and then analyzed its infectiveness in the M8166
T cells in vitro.
a
mRESULTS
Transcriptional activities of mutated SIV LTRs
A series of mutant LTRs containing pTet was con-
structed, and the LTRs’ promoter function was examined.
Four mutant LTRs were constructed by PCR using pU-
CLTR-CAT as a template with one forward and four
reverse mutant LTR primers (Fig. 1A). All the mutant LTRs
underwent deletion of the NF-kB and Sp1 binding sites
nd TATA box motif, while they maintained the intact 59
TR integration sites and polypurine tract (PPT) se-
uence. Each mutant differed in the extent of the deletion
n the upstream U3 region (Fig. 1A). pTet was inserted
nto the XhoI site in the deleted region. These mutant
TRs containing pTet were designated pMLTRTETIF/1R,
F/2R, 1F/4R, and 1F/5R.
To investigate the transcriptional activities of these
utant LTRs, in which a chloramphenicol acetyltrans-
erase (CAT) gene was inserted downstream of these
utant LTRs, a CAT reporter assay was performed.
ransfection to Tet-on HeLa cells was performed under
our conditions: Dox(2)Tat(2); Dox(1)Tat(2); Dox(2)Tat(1);
ents in the SIV LTR U3 region and the primers to make mutant LTRs.
and the site of pTet insertion are indicated. The primers used for theal elemnd Dox(1)Tat(1) (Fig. 2). CAT expression from all the
utant LTRs was observed in the presence of Dox; their
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of wild-type LTR-CAT activity), except for pMLTRTET 1F/
1R. We did not use pMLTRTET 1F/1R, which retains
pre-NF-kB sequence for further construction, since it
produces the highest amount of leakage in the absence
of Dox (12% of wild-type pUCLTR-CAT reporter). The
mutant LTRs’ promoter activities increased following the
coexpression of Tat and in the presence of Dox reached
81.9% in 1F/1R, 127.0% in 1F/2R, 142.8% in 1F/4R, and
166.5% in 1F/5R, compared with wild-type LTR CAT ac-
tivity (100%). Increased deletion in the U3 upstream re-
gion tended to increase the promoter activities of MLTR-
TETs.
These results indicated that the transcription of all the
mutant LTRs could be controlled by Dox as transacti-
vated by Tat and that the transcription levels in the
presence of Dox and Tat are comparable to or higher
than that of wild-type LTR. These results suggest that
replacing the original promoters with pTet was success-
ful with respect to the desired effect on promoter func-
tion.
The viral production in Tet-on HeLa cell line
pSIVmac239 D nef with MLTRTETs was constructed
and examined for expression of the viral protein. Both 59
and 39 LTRs were replaced to prevent possible recom-
bination. The original LTRs were replaced by three mu-
tant LTRs whose expression was tightly controlled by
Dox. These plasmids encoding the whole viral genomes
were designated pSIV-2R, pSIV-4R, and pSIV-5R. These
plasmids were transfected to Tet-on HeLa cells under
four conditions: Dox(2) Tat(2); Dox(1) Tat(2); Dox(2)
Tat(1); and Dox(1) Tat(1). The expression of the viral
FIG. 2. Relative percentage of CAT activity produced by pMLTRTprotein was investigated using a p27 core antigen cap-
ture assay.In the presence of Dox, p27 was efficiently produced
from the cultures transfected with all the plasmids con-
taining MLTRTETs (Fig. 3). In contrast, in the absence of
Dox, the production of p27 was less than 15% even under
Tat transactivation. The Dox-dependent production of
p27 reached a maximum with cotransfection by the Tat
expressing plasmid. The p27 production induced by Dox
and Tat was 65.8% in pSIV-2R, 98.7% in pSIV-4R, and
57.4% in pSIV-5R, compared with their parental pSIV-
mac239 D nef. These results suggest that pTet in mutant
iruses can regulate expression of the viral protein in the
ontext of the entire viral genome in a Dox-dependent
anner.
Viral RNAs in the medium of the cells that had been
ultured in the presence of Dox and Tat, which showed
maximum production of p27, were quantified by quan-
itative RT-PCR, which amplified the gag region. Results
showed that the number of RNA copies of pSIVDnef is
about 102 and 103 higher than that of pSIV-2R and
SIV-4R and is 104 higher than that of pSIV-5R (Fig. 3B).
The number of RNA copies of these viruses was signif-
icantly low, compared with p27 expression of these vi-
ruses. The difference between p27 expression and RNA
copies of these viruses may be due to the weak ability of
mutant SIVs to package viral genome RNA into virions.
The viral infection and integration analysis
To examine whether infectious particles were formed
from the viral genomes containing mutant LTRs, the su-
pernatants from Tet-on HeLa cells transfected with pSIV-
2R, pSIV-4R, and pSIV-5R were used to infect M8166
cells. The genomic DNA from these M8166 cells was
extracted 24 h after infection and analyzed for the exis-
omparison with that of pUCLTR-CAT in the HeLa rtTA cell line.tence of the DNA form of the viral genomes by PCR using
three primer pairs, which amplified the R/U5 region of the
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271Dox-DEPENDENT SIVmac WITH TETRACYCLINE-INDUCIBLE PROMOTERLTR, the 59LTR-gag region, and the 2-LTR. Similar
amounts of viral DNA were detected by the different
primer pairs in all the cultures infected with the mutant
and wild-type viruses (Fig. 4). The detection viral DNA
showed that infectious viral particles were formed from
all the mutant viral genomes. In addition, the detection of
the LTR-gag region indicated that the reverse transcrip-
tion step proceeded up to the second-strand transfer
stage in these viruses. Moreover, the detection of the
2-LTR form suggests that the circularization of the viral
genome was imported into the nucleus and that the
viruses may integrate into the M8166 cell chromosome.
DISCUSSION
There are major safety concerns surrounding the use
of live attenuated retrovirus vaccines. The attenuated
virus will remain active within the vaccinee for his or her
FIG. 3. (A) Relative p27 core antigen expression activated from SIVm
HeLa cells. (B) The viral copy number in the supernatant from the trans
and pSIV with mutant LTRs in the presence of Dox and Tat expressingentire life. The pathogenic potential of an attenuated
genotype has been demonstrated in neonatal macaques
c
w(Baba et al., 1995) and a small proportion of normal adult
acaques (Cohen, 1997). Achieving the correct balance
etween immunogenicity and pathogenesis is important
o prevent the onset of AIDS. One way to do this is to
ontrol viral replication in a drug-dependent manner by
onstructing an attenuated virus with a drug-inducible
romoter. We showed that viruses with a dox inducible
romoter could express viral protein in a Dox-dependent
anner and proceed through one round of a whole viral
ife cycle.
To obtain Dox-regulated viruses, several reporters
ith mutant LTRs were constructed and analyzed for
heir promoter activity by the CAT reporter assay. Ideally
3 transcriptional elements should be deleted as much
s possible, but without affecting virus replication, in
rder to closely regulate viral expression. Only minimal
asic transcriptional activity is allowed in a noninducible
mutants with pTet in comparison with that of pSIVmacDnef in Tet-on
Tet-on HeLa cells. Cells were transfected with the plasmids pSIVDnef
r.ac239ondition after the inducible promoter is introduced. pTet
as chosen because it has been proven to be a very
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272 XIAO ET AL.good on–off switch with minimal leakage (Gossen and
Bujard, 1992; Gossen et al., 1995). The pTet in mutant SIV
LTRs compensated for the function of the original tran-
scription elements in the U3 region of wild-type LTRs in
the presence of Dox, and it was successfully regulated
and showed little basic activity in the absence of Dox.
pMLTRTET 1F/1R CAT has the highest level of residual
activity in the absence of Dox. Its pre-NF-kB sequence
may account for this, as was suggested in a report
concerning SIVmac239 missing the entire core enhancer
region (Ilyinskii and Desrosiers, 1996; Ilyinskii et al.,
1997). Although among pMLTRTET 1F/2R, 4R, and 5R,
there are no marked differences, there does seem to be
increasing transcriptional activities in the presence of
FIG. 4. The detection of viral DNA in M8166 cells infected with mutant
viruses, SIV-2R (lane 1), SIV-4R (lane 2), SIV-5R (lane 3), M8166 (lane 4),
SIVmac D nef (lane 5), and MA239 (lane 6). Virus stocks were prepared
from Tet-on HeLa cells transfected with mutant SIVs. All the virus
stocks contained the same amount of p27. The DNA was collected 24 h
postinfection. PCR was carried out by using three pairs of primers (A)
R/U5 PCR of proviral DNA with MLTR1F/SIV LTR R primer pairs, (B)
59LTR-gag PCR of proviral DNA with MLTR1F/MG1655R primer pair,
and (C) 2-LTR PCR of proviral DNA with MLTR1F/MLTR5R primer pair.Dox and tat, proportional to the extent of the deletion in
the U3 region upstream. This region does not contain the
i
csequence known to have the binding sites for transcrip-
tion factors but contains a modular sequence, which is
conservative in all retrovirus U3 regions (Frech et al.,
1996). The deleted modular element sequence may thus
have some regulatory function in transcription.
Under the condition of Dox(1)Tat(1), the gag p27
expression from pSIVs with mutant LTRs was compara-
ble to that pSIVDnef in Tet-on HeLa cells. In contrast, the
number of viral RNA copies of pSIVs with mutant LTRs
were 102 to 104 lower than that of pSIVDnef. Although the
mount of RNA was low in SIVs with mutant LTRs, this
ndicated that the inducible SIVs could at least finish the
ranscription and the packaging of the viral RNA into
irion particles. Low copy number in the virion particles
ay be due to the weak ability of SIVs with mutant LTRs
o package the viral genome RNA. These viruses com-
only lack the region containing NF-kB, Sp1 binding
ites, and pre NF-kB sequence, which was believed to
be a strong enhancer for efficient SIV replication (Ilyinskii
and Desrosiers, 1996; Ilyinskii et al., 1997). The region
that was commonly deleted may function in the efficient
packaging process.
The viral particles from SIV-containing mutant LTRs
with a tet promoter were found to be infectious as shown
in the detectable viral DNA in the infected M8166 cells.
There was no difference in infectivity among SIV-2R,
SIV-4R, and SIV-5R and wild-type LTR. Mutant LTR, es-
pecially the LTR-gag and 2-LTR regions, can be detected
in these virus-infected cells, and this suggests that viral
particles derived from these constructs can infect CD4
cells and proceed through reverse transcription and in-
tegration steps. Thus, these Dox-dependent viruses
were shown to proceed through one cycle of virus rep-
lication.
To establish the Tet-on system in SIV, constitutive
expression of pTet transactivator, rtTA, is required. The
attempts to make replication-competent mutant SIVs
with the rtTA gene in the nef region were not successful
(data not shown). Because even SIV D nef with the rtTA
gene cannot replicate, the size of the rtTA gene (1.05 kb)
may exceed the size for virus to carry for replication.
Another way of supplying rtTA is to use CD41 HeLa or T
ell lines that express rtTA and that are susceptible to
IV infection. However, such a cell line is not available
ow, though we are trying to establish it. Therefore, it is
urrently impossible to analyze more than one replica-
ion cycle for Dox-dependent SIVs with mutant LTRs.
Although only one cycle of virus replication under the
egulation of Dox was confirmed in the present study, the
Tet in the SIV genome containing mutant LTRs may
unctionally take the place of the original transcription
lements, thus efficiently transcribing the whole viral
enome to produce infectious viral particles that can
1nfect and be integrated into CD4 cells. To achieve a
ontinuous replication cycle, constitutive integration of
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273Dox-DEPENDENT SIVmac WITH TETRACYCLINE-INDUCIBLE PROMOTERthe rtTA gene into the SIV genome containing mutant
LTRs is required. The on–off system of viral replication
may provide not only an opportunity to develop a safer
live vaccine but also a unique experimental model with
which to investigate the mechanism underlying virus
replication.
MATERIALS AND METHODS
Construction of mutant LTR-CAT reporters
SIV 39 LTR with polypurine tract was amplified from
pMA239, which contains the whole genome of SIV-
mac239 (Shibata et al., 1991), by PCR with primers that
have PstI and SalI sites (SIV LTR, F 59-AAACTGCAGTCT-
CATTTTATAAAAGAAAAGGGGGGAC-39; and SIV LTR,
59-CCACGCGTCGACTGCTAGGGATTTTCCTGCTTCG-39).
he generated fragment was cloned into the correspond-
ng sites in pUC119 to construct pUCLTR. The whole CAT
ene fragment, which contains an early poly(A) signal of
V40 at its 39 end, was cut out from the pSV2CAT plasmid
y HindIII/BamHI double-digestion and then cloned into
he same sites of a pBluescript SK plasmid to form
BluescriptCAT. The SalI/BamHI fragment from pBlue-
criptCAT was subcloned into the corresponding sites of
UCLTR, forming pUCLTR-CAT.
Two forward and four reverse mutant LTR primers in the
3 region were designed with the XhoI enzyme linker
MLTRIF, 59-GCCGCTCGAGCACTGCATTTCGCTCTGTATT-
AGTC-39; MLTR2F, 59GCCGCTCGAGGGGAACGCCCACT-
TCTTGATGTAT-39; MLTR1R, 59-CCCGCTCGAGCTGTTTC-
GCGAGTTTCCTTCTTGTCAG-39; MLTR2R, 59-GGCGCT-
GAGCTTGCTTCCAAACTCTTCTGGGTAT-39; MLTR4R, 59-
CCGCTCGAGAATGTCTTTGGGTATCTAATTCCTGGTC-39;
nd MLTR5R, 59-CCCGCTCGAGTGGTATGATGCCTTCTTC-
TTTTCTAAGTA-39). The primer locations are illustrated in
ig. 1. PCR was conducted by using a pUCLTR-CAT plas-
id as a template to amplify itself directly, forming mutant
LTRCAT (pMLTR-CAT) by XhoI digestion of the PCR frag-
ent and self-ligation. The region outside of the amplified
lasmid was deleted after self-ligation.
One pair of primers with an XhoI linker was designed
o amplify pTet using pUHD10-3 plasmid as a template
Tet(o) F 59-CCTATAAAAATAGGCGTATCACGAGGC-39;
et(o) R 59-CCCGCTCGAGTACTCGACCCGGGTACCGAG-
9), and this fragment was introduced into the XhoI site of
MLTR-CATs, forming pMLTRTET1F/1R, 1F/2R, 1F/4R,
nd 1F/5R reporters. All PCR-derived inserts were se-
uenced to confirm that only the intended changes were
ntroduced.
ells
1A CD4 human cell line M8166 (a subclone of C8166
Clapham et al., 1987)) was maintained in RPMI 1640
p
redium containing 10% heat-inactivated fetal calf serum
FCS). Tet-on HeLa cells that constitutively express trans-
ctivator rtTA were maintained in DMEM medium con-
aining 10% heat-inactivated FCS and G418 at 400 mg/ml.
ransactivation assay
Tet-on HeLa cells were seeded into a six-well plate at
concentration of 105 per well, and 12 h later the cells
ere transfected with 1 mg of the various pMLTRTET-
CAT reporters or cotransfected with or without 0.05 mg
IV pSR a Tat expression plasmid using Lipo-
FECTAMINE (Gibco BRL) as the transfection reagent, in
the presence or in the absence of Dox (2 mg/ml). It has
een reported that the SIVmac239 LTR can be transac-
ivated by HIV-1 Tat, which is similar to SIV Tat (Sakuragi
t al., 1991). The cells were harvested 48 h after trans-
ection, and the amount of CAT was quantified with a CAT
nzyme-linked immunosorbent assay (ELISA) kit (Boehr-
nger). To allow better comparison within the experiment,
IVmac wild-type pLTRCAT reporter was used as a pos-
tive control. The amount of CAT produced by wild-type
LTRCAT was considered as 100% activity, and those of
utant LTRs were determined relative to this value. Fur-
hermore, 0.1 mg of a plasmid, pCDM-b-gal, expressing
the b-galactosidase gene under control of the CMV pro-
oter was transfected as an internal control to adjust
ransfection efficiencies.
onstruction of SIVmac with mutant LTR
pSIV LE, which contains the sequence from 59LTR to
he env 39 end, was constructed (i) by replacing the
fragment 59env-39 LTR between the NheI site (nt 8742 of
pMA239) and the EcoRI site of pMA239 with the fragment
between the NheI and the EcoRI sites of pSKenv, (ii) by
amplifying the region from the env NheI site (nt 8742 of
pMA239) to the 39 end of env stop codon (nt 9059 of
pMA239), and (iii) by adding an EcoRV site introduced
just after the env stop codon. The infectious clone pSIV-
mac D nef was constructed by inserting the blunted
fragment, which was generated by digesting pSKLTR
with EcoRV and SacI, into the EcoRV site of pSIV LE;
pSKLTR and pSKMLTRTET were constructed by inserting
the fragment between the PstI and the BamHI sites of
pUC LTR and pUC MLTRTETs, respectively, into the cor-
responding sites in pBluescript SK. Mutation was first
introduced into the 39end of pSIVmac D nef by replacing
he region located between the EcoRV and the NotI sites
f a 39LTR with the corresponding fragment of pSKML-
RTETs to form pSIVmac D n39MLTRs. pSKLTR HB,
hich contains the 59LTR, was constructed by cloning
he fragment that was generated by digestion by pMA239
ith HindIII and BamI into the corresponding sites of
Bluescript SK. pSKMLTRTET HBs were constructed by
eplacing the DraII generating fragment from SKLTR HB
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274 XIAO ET AL.with the corresponding fragment from pSKMLTRTETs.
pSIVmac D nef with mutant LTRs at both ends (pSIV-2R,
SIV-4R, and pSIV-5R) was constructed by replacing the
ragment between the EheI (nt 1082 of pMA239) and the
otI sites of pSK MLTRTET HBs with the corresponding
ragment of pSIVmac D 39MLTRTETs.
roduction of virus stock
To produce viruses, semiconfluent Tet-on HeLa cells
ere transfected with 2 mg of full-length proviral DNA
constructs by LipoFECTAMINE as described above. The
cell culture supernatants were prepared 48 h postrans-
fection, passed through a 0.45-mm-pore-size filter, and
stored at 280°C. These supernatants were used to in-
fect M8166 cells.
Viral DNA detection
M8166 cells that split 1:2 to 1:5 the previous day were
infected with virus stock containing 2 ng of p27, incu-
bated at 37°C in a CO2 incubator for 3 h, washed five
times with PBS, and cultured in RPMI 1640 with 10% FCS.
To prepare templates for PCR, the infected cells were
digested with proteinase K for 4 h at 56°C, and then
proteinase K was inactivated by heating for 10 min at
99°C. PCR was carried out by using three primer pairs: A,
R/U5 PCR of viral DNA by MLTR1F/SIV LTR R primers; B,
59LTR-gag PCR of viral DNA by MLTR1F/MG1655R prim-
ers (MG1665R nt 1883–1910 of pMA239, 59-CACAC-
CTCTGGTAGTTCGCCGATACGT-39); and C, 2-LTR PCR
f proviral DNA by MLTR2F/MLTR5R primers. After de-
aturation of the template DNA at 96°C for 5 min, the
NAs were amplified for 30 cycles under the following
onditions: denaturation at 96°C for 50 s, annealing at
5°C for 60 s, and extension at 72°C for 90 s. A final
xtension at 72°C for 10 min was added to the last cycle.
he PCR products were checked using 1% agarose gel
lectrophoresis.
uantitative RT-PCR for viral genome
The supernatants from Tet-on HeLa cells transfected
ith the viral plasmids in the presence of Dox (2 mg/ml)
nd Tat expressing vector were filtered through a
.45-mm filter, and then the viral RNA was extracted by
rizol reagent (Gibco, BRL). RT reaction and PCR were
erformed with a Taqman RT-PCR kit (Perkin–Elmer)
Suryanarayana et al., 1998) using these RNA samples
orresponding to 20 ml of the supernatant. Primers are
SIV II-696 F (59-GGAAATTACCCAGTCCAACAAATAGG-39)
and SIV II-784 R (59-TCTATCAATTTTTACCCAGGG-
CATTTA-39). A labeled probe, SIV II-731 (59-FAM-TGTC-
CACCTGCCATTAAGCCCG-TAMARA-39), was used for
detection of 59-nuclease activity. For each run, a standard
curve was generated using serially dilutions of an in vitro
transcript containing the gag region. The RT-PCR wascarried out and analyzed with a Prism 7700 sequence
detector system.
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